159 related articles for article (PubMed ID: 8975352)
41. Selection of drugs to treat gastro-oesophageal reflux disease: the role of drug interactions.
Flockhart DA; Desta Z; Mahal SK
Clin Pharmacokinet; 2000 Oct; 39(4):295-309. PubMed ID: 11069215
[TBL] [Abstract][Full Text] [Related]
42. Treating gastro-oesophageal reflux disease during pregnancy and lactation: what are the safest therapy options?
Broussard CN; Richter JE
Drug Saf; 1998 Oct; 19(4):325-37. PubMed ID: 9804446
[TBL] [Abstract][Full Text] [Related]
43. Co-prescription of alginate based formulations & proton pump inhibitors (PPIs) in gastro-oesophageal reflux disease: time for rethink?
Davis S; Kshirsagar NA
Indian J Med Res; 2006 Apr; 123(4):493-6. PubMed ID: 16783039
[No Abstract] [Full Text] [Related]
44. Low-dose or standard-dose proton pump inhibitors for maintenance therapy of gastro-oesophageal reflux disease: a cost-effectiveness analysis.
You JH; Lee AC; Wong SC; Chan FK
Aliment Pharmacol Ther; 2003 Mar; 17(6):785-92. PubMed ID: 12641500
[TBL] [Abstract][Full Text] [Related]
45. Omeprazole.
Cheung G
Conn Med; 1990 Jul; 54(7):392-3. PubMed ID: 2394098
[TBL] [Abstract][Full Text] [Related]
46. Treatment of reflux disease during pregnancy and lactation.
Dağlı Ü; Kalkan İH
Turk J Gastroenterol; 2017 Dec; 28(Suppl 1):S53-S56. PubMed ID: 29199169
[TBL] [Abstract][Full Text] [Related]
47. Review article: the management of heartburn during pregnancy and lactation.
Thélin CS; Richter JE
Aliment Pharmacol Ther; 2020 Feb; 51(4):421-434. PubMed ID: 31950535
[TBL] [Abstract][Full Text] [Related]
48. Sucralfate gel versus placebo in patients with non-erosive gastro-oesophageal reflux disease.
Simon B; Ravelli GP; Goffin H
Aliment Pharmacol Ther; 1996 Jun; 10(3):441-6. PubMed ID: 8791975
[TBL] [Abstract][Full Text] [Related]
49. [Therapeutic strategy in the treatment of gastroesophageal reflux].
Zeitoun P; Carteret E; Bouché O
Acta Gastroenterol Belg; 1990; 53(5-6):568-72. PubMed ID: 1983374
[TBL] [Abstract][Full Text] [Related]
50. [Therapy of reflux esophagitis with antacids].
Weihrauch TR
Z Gastroenterol; 1983 Mar; 21 Suppl():50-2. PubMed ID: 6344504
[TBL] [Abstract][Full Text] [Related]
51. [Therapeutic principles in gastroesophageal reflux].
Chassany O; Elkharrat D; Bergmann JF; Segrestaa JM
Rev Med Interne; 1995; 16(12):960-70. PubMed ID: 8570962
[TBL] [Abstract][Full Text] [Related]
52. [Therapy of esophageal reflux disease].
Rösch W
Dtsch Med Wochenschr; 1982 Mar; 107(10):389-91. PubMed ID: 6277588
[No Abstract] [Full Text] [Related]
53. Gastro-oesophageal reflux.
Lee MG
West Indian Med J; 1994 Mar; 43(1):9-11. PubMed ID: 7913565
[No Abstract] [Full Text] [Related]
54. Managing reflux in infants: lifestyle modifications or medications?
Heiberger A
S D Med; 2014 Jun; 67(6):237-8. PubMed ID: 24979984
[No Abstract] [Full Text] [Related]
55. National Practice Patterns of Antireflux Medication for Chronic Rhinosinusitis.
Gilani S; Pynnonen MA; Shin JJ
JAMA Otolaryngol Head Neck Surg; 2016 Jul; 142(7):627-33. PubMed ID: 27281111
[TBL] [Abstract][Full Text] [Related]
56. [Gastroesophageal reflux disease. 2. Drug therapy].
Amano K; Kinoshita Y
Nihon Naika Gakkai Zasshi; 2000 Jan; 89(1):68-73. PubMed ID: 10723919
[No Abstract] [Full Text] [Related]
57. Morning or evening dosage of omeprazole for gastro-oesophageal reflux disease?
Savarino V; Mela GS; Vigneri S
Aliment Pharmacol Ther; 1996 Jun; 10(3):447-8. PubMed ID: 8791976
[No Abstract] [Full Text] [Related]
58. What is intensive therapy for gastroesophageal reflux?
Wolfe MM
Gastroenterology; 1992 Nov; 103(5):1696-8. PubMed ID: 1426891
[No Abstract] [Full Text] [Related]
59. [Indication for conservative therapy of reflux esophagitis (author's transl)].
Ottenjann R
Langenbecks Arch Chir; 1978 Nov; 347():285-8. PubMed ID: 732429
[TBL] [Abstract][Full Text] [Related]
60. High prevalence of abnormal acid gastro-oesophageal reflux in idiopathic pulmonary fibrosis.
Han MK
Eur Respir J; 2006 Oct; 28(4):884-5; author reply 885. PubMed ID: 17012636
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
